Theracare Pain Relief 4% Lidocaine Patch
NDC Package 71101-059-05
Package Information
Theracare Pain Relief 4% Lidocaine (lidocaine) patches is a medication used to help reduce itching and pain from certain skin conditions (such as scrapes, minor skin irritations, insect bites). This formulation utilizes a patch delivery system. Marketed by Veridian Healthcare, this product is identified by NDC 71101-059 and is authorized under FDA application M017.
Identification & Billing
- RxCUI: 1737778 - lidocaine 4 % Medicated Patch
- RxCUI: 1737778 - lidocaine 0.04 MG/MG Medicated Patch
Clinical Specifications
- Percutaneous - Administration through the skin.
- Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
- Transdermal - Administration through the dermal layer of the skin to the systemic circulation by diffusion.
Regulatory & Marketing
Hierarchy Structure
- 71101 - Veridian Healthcare
- 71101-059 - Theracare Pain Relief 4% Lidocaine
- 71101-059-05 - 5 POUCH in 1 BOX / 1 g in 1 POUCH
- 71101-059 - Theracare Pain Relief 4% Lidocaine
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 71101-059-05 identifies a specific commercial package of 5 pouch in 1 box / 1 g in 1 pouch of Theracare Pain Relief 4% Lidocaine, a human over the counter drug labeled by Veridian Healthcare. This patch is formulated for percutaneous; topical; transdermal use and contains lidocaine as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Veridian Healthcare on February 01, 2025. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This product is used to help reduce itching and pain from certain skin conditions (such as scrapes, minor skin irritations, insect bites). It may also be used to help relieve nerve pain after shingles (infection with herpes zoster virus). Lidocaine belongs to a class of drugs known as local anesthetics. It works by causing a temporary loss of feeling in the area where you apply the patch.
How is this Veridian Healthcare product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 71101005905. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.